At a glance
- Originator Merck & Co
- Class Analgesics; Oxazoles
- Mechanism of Action Fatty acid amide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 27 May 2016 Chemical information added
- 15 Jul 2009 Phase-I clinical trials in Pain in USA (unspecified route)